LegalizeCommission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
| I, the undersigned official veterinarian hereby certify that the animals of the consignment described in Part I: II.1. come from a third country or territory, zone thereof with code - (1)which, on the date of issue of this animal health certificate is authorised for the entry into the Union of dogs, cats and ferrets and is listed in Part 1 of Annex VIII to Commission Implementing Regulation (EU) 2021/404; (2) either [II.2. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;] (2) (3) or [II.2. have undergone one single assembly operation in the country or territory, or zone thereof of origin which took place for not more than 6 days in an establishment fulfilling the following requirements: (a) it is approved for conducting assembly operations of dogs, cats and ferrets by the competent authority in the third country or territory in accordance with Article 10 of Commission Delegated Regulation (EU) 2019/2035; (b) it has a unique approval number assigned by the competent authority of the third country or territory; (c) it is listed for that purpose by the competent authority of the third country or territory of dispatch to the Union, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035; (d) it complies with the record keeping requirements provided for in Article 73(2), point (a)(iv), of Delegated Regulation (EU) 2020/692;] (2) (3) or [II.2. have been dispatched from an animal shelter fulfilling the following requirements: (a) it is approved by the competent authority in the third country or territory in accordance with Article 11 of Delegated Regulation (EU) 2019/2035; (b) it has a unique approval number assigned by the competent authority of the third country or territory; (c) it is listed for that purpose by the competent authority of the third country or territory of dispatch, including the information provided for in Article 21 of Delegated Regulation (EU) 2019/2035;] II.3 have been subjected with negative result to a clinical inspection, carried out by an official veterinarian in the third country or territory of origin, or zone thereof within the last 48 hours prior to the time of loading for dispatch to the Union for the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; (2) either [II.4. are destined for direct entry into the Member State of destination to be isolated in (2) either [a confined establishment;]] (2) or [an approved quarantine establishment;]] (2) or [II.4. were at least 12 weeks old at the date of vaccination against rabies and at least 21 days have elapsed since the date of completion of the primary anti-rabies vaccination (5) carried out in accordance with the validity requirements set out in Annex III to Regulation (EU) No 576/2013 of the European Parliament and of the Council, and any subsequent revaccination was carried out within the period of validity of the preceding vaccination (6), and (2) either [come from, and in the case of transit are scheduled to transit through, a third country or territory listed in Annex II to Commission Implementing Regulation (EU) No 577/2013 and details of the relevant anti-rabies vaccination(s) are provided in columns 1 to 7 in the table below;]] (2) or [come from or are scheduled to transit through a third country or territory not listed in Annex II to Commission Implementing Regulation (EU) No 577/2013, and: (a) the details of the relevant anti-rabies vaccination(s) are provided in columns 1 to 7 in the table below, (b) a rabies antibody titration test (7), carried out on a blood sample taken by the veterinarian authorised by the competent authority not less than 30 days after the date of the preceding vaccination and at least 3 months prior to the date of issue of this animal health certificate, proved an antibody titre equal to or greater than 0,5 IU/ml (8) and any subsequent revaccination was carried out within the period of validity of the preceding vaccination, and the date of sampling for testing the immune response are provided in column 8 in the table below:]] Transponder Date of vaccination [dd/mm/yyyy] Name and manufacturer of vaccine Batch number Validity of vaccination Date of blood sampling [dd/mm/yyyy] Alphanumeric code of the animal Date of implantation and/or reading (9) [dd/mm/yyyy] From [dd/mm/yyyy] To [dd/mm/yyyy] 1 2 3 4 5 6 7 8 (2) either [II.5. include dogs destined for a Member State listed in the Annex to Commission Implementing Regulation (EU) 2018/878 and those dogs have been treated against infestation with Echinococcus multilocularis, and the details of the treatment carried out by the administering veterinarian in accordance with point 2 of Annex XXI to Delegated Regulation (EU) 2020/692 (10) (11) are provided in the table below: Transponder or tattoo. Alphanumeric code of the dog Anti-Echinococcus treatment Administering veterinarian Name and manufacturer of the product Date [dd/mm/yyyy] and time of treatment [00:00] Name in capitals, stamp and signature ] (2) or [II.5. include dogs which have not been treated against infestation with Echinococcus multilocularis.] (2) or [II.5. include dogs destined for direct entry into the Member State of destination to be isolated in (1) either [a confined establishment.]] (1) or [an approved quarantine establishment.]] (2) (3) [II.6. were loaded for dispatch to the Union on //____(dd/mm/yyyy) (4) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory, and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized.] Notes: This animal health certificate is intended for commercial entries into the Union of dogs, cats and ferrets, including when they are destined to a confined establishment or to an approved quarantine establishment and when the Union is not the final destination of the animals and for the entry into the Union of dogs, cats and ferrets moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the European Parliament and of the Council. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.20 : Certified as or for: Indicate: — “Further keeping” where dogs, cats or ferrets are moved in accordance with Title 5 of Part II of Delegated Regulation (EU) 2020/692; — Confined establishment: As defined in Article 4, point (48), of Regulation (EU) 2016/429 of the European Parliament and of the Council; — Approved quarantine establishment: As defined in Article 3(9) of Commission Delegated Regulation (EU) 2020/688; — “Others” where dogs (Canis lupus familiaris), cats (Felis silvestris catus) or ferrets (Mustela putorius furo) are moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the European Parliament and of the Council. Part II: (1) Code of the zone as it appears in column 2 of the table in Part 1 of Annex VIII to Implementing Regulation (EU) 2021/404. (2) Delete if not applicable. (3) Not applicable to the movement of dogs, cats and ferrets other than non-commercial movements, kept as pet animals in households that may not be carried out in accordance with the conditions laid down in Article 245(2) or Articles 246(1) and (2) of Regulation (EU) 2016/429. (4) Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. (5) Any revaccination shall be considered a primary vaccination if it was not carried out within the period of validity of a previous vaccination. (6) A certified copy of the identification and vaccination details of the animals concerned shall be attached to the animal health certificate. (7) The rabies antibody titration test referred to in point II.4: (a) shall be carried out on a sample collected by a veterinarian authorised by the competent authority, at least 30 days after the date of vaccination and 3 months prior to the date of dispatch to the Union; (b) shall measure a level of neutralising antibody to rabies virus in serum equal to or greater than 0,5 IU/ml; (c) shall be performed by an official laboratory; (d) shall not be renewed on an animal, which following that test with satisfactory results, has been revaccinated against rabies within the period of validity of a previous vaccination. A certified copy of the official report from the official laboratory on the result of the rabies antibody test referred to in point II.4 shall be attached to the animal health certificate. (8) By certifying this result, the official veterinarian confirms that he has verified, to the best of his ability and where necessary with contacts with the laboratory indicated in the report, the authenticity of the laboratory report on the results of the antibody titration test referred to in point II.4. (9) In conjunction with note (6), the marking of the animals concerned by the implantation of a transponder shall be verified before any entry is made in this animal health certificate and shall always precede any vaccination, or where applicable, testing carried out on those animals. (10) The treatment against infestation with Echinococcus multilocularis referred to in point II.5 shall: (a) be administered by a veterinarian within not more than 48 hours and not less than 24 hours prior to the time of the scheduled dispatch of the dogs to one of the Member States or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878; (b) consist of an approved medicinal product which contains the appropriate dose of praziquantel or pharmacologically active substances, which alone or in combination, have been proven to reduce the burden of mature and immature intestinal forms of Echinococcus multilocularis in the host species concerned. (11) The table referred to in point II.5 shall be used to document the details of a further treatment if administered after the date the animal health certificate was signed and prior to the scheduled entry into one of the Member States or parts thereof listed in the Annex to Implementing Regulation (EU) 2018/878. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 39
MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-A-ENTRY”)
Part I: Description of consignment
| COUNTRY | Animal health certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| --- | --- |
| I.18 | Transport conditions |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| --- | --- |
| I.21 | ☐ For transit |
| Third country | |
| --- | --- |
| I.24 | Total number of packages |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
| Type | |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model BOV-SEM-A-ENTRY | Certificate model BOV-SEM-A-ENTRY | Certificate model BOV-SEM-A-ENTRY | Certificate model BOV-SEM-A-ENTRY |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| I, the undersigned official veterinarian, hereby certify that: II.1. The semen of the consignment described in Part I is intended for artificial reproduction and was obtained from donor animals which originate from a third country or territory, or zone thereof: II.1.1. authorised for the entry into the Union of semen of bovine animals and listed in Annex IX to Commission Implementing Regulation (EU) 2021/404; (1) either [II.1.2. where foot and mouth disease was not reported for at least 24 months immediately prior to the date of collection of the semen and until its date of dispatch to the Union;] (1) (2) or [II.1.2. where foot and mouth disease was not reported for a period starting on the date //____ (dd/mm/yyyy) immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union;] II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease were not reported for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union; II.1.4. where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and (1) either [no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period.] (1) or [vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.] II.2. The semen of the consignment described in Part I was obtained from donor animals which, prior to the date of the commencement of the quarantine referred to in point II.4.6, originated from establishments: II.2.1. situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days and in which foot and mouth disease has not been reported during at least 3 months, and (1) either [in which they were not vaccinated against foot and mouth disease;] (1) or [in which they were vaccinated against foot and mouth disease during the last 12 months prior to the date of collection of the semen but not of the last 30 days immediately prior to the date of collection of the semen, and in which 5% (with a minimum of five straws) of each quantity of semen taken from a donor animal at any time is submitted to a virus isolation test for foot and mouth disease with negative results;] II.2.2. free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and they have never been kept previously in any establishment of a lower health status; II.2.3. free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status; (1) either [II.2.4. free from enzootic bovine leukosis and they have never been kept previously in any establishment of a lower health status;] (1) or [II.2.4. not free from enzootic bovine leukosis and they are younger than 2 years of age and they have been produced by dams which have been subjected, with negative results, to a serological test for enzootic bovine leukosis after the date of removal of the animal from the dam;] (1) or [II.2.4. not free from enzootic bovine leukosis and they have reached the age of 2 years, and they have been subjected, with a negative result, to a serological test for enzootic bovine leukosis;] (1) either [II.2.5. free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have never been kept previously in any establishment of a lower health status;] (1) or [II.2.5. not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have been subjected, with a negative result, to a serological test (whole virus) on a blood sample;] II.2.6. in which (1) either [surra (Trypanosoma evansi) has not been reported during the last 2 years.] (1) or [surra (Trypanosoma evansi) has not been reported for at least 30 days and when the disease was reported in the establishments during the last 2 years, following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments.] II.3. The semen of the consignment described in Part I has been collected, processed and stored, and dispatched from the semen collection centre (3) which: II.3.1. is approved and listed by the competent authority of the third country or territory; II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686. II.4. The semen of the consignment described in Part I was obtained from donor animals which: II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease; II.4.2. remained for at least 6 months prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7; II.4.3. did not show symptoms or clinical signs of transmissible animal diseases on the date of their admission to a semen collection centre and on the date of collection of the semen; II.4.4. are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692; II.4.5. for at least 30 days prior to the date of collection of the semen and during the collection period: II.4.5.1. were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia or lumpy skin disease, or of an emerging disease relevant for bovine animals; II.4.5.2. were kept on a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24), bovine genital campylobacteriosis and trichomonosis have not been reported; II.4.5.3. were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.5.1 or from establishments which do not meet the conditions referred to in point II.4.5.2; II.4.5.4. were not used for natural breeding; II.4.6. have been subjected to a quarantine for at least 28 days in quarantine accommodation, where only other cloven-hoofed animals with at least the same health status were present, which on the date of their admission to the semen collection centre complied with the following conditions: II.4.6.1. it was not situated in a restricted zone established due to diseases referred to in point II.4.5.1; II.4.6.2. none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days; II.4.6.3. it was situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the quarantine accommodation for at least 30 days; II.4.6.4. has had no outbreak of foot and mouth disease reported during at least 3 months preceding the date of admission of the animals into the semen collection centre; II.4.7. were kept in the semen collection centre: II.4.7.1. which was not situated in a restricted zone established due to diseases referred to in point II.4.5.1; II.4.7.2. where none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days prior to the date of collection of the semen, and (1) (4) [at least 30 days following the date of collection of the semen;] (1) (5) [until the date of dispatch of the consignment to the Union;] II.4.7.3. situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the semen collection centre for at least 30 days; and: (1) (4) either [free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and 30 days from the date of its collection;] (1) (5) or [free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union and they have been kept at that semen collection centre for a continuous period of at least 30 days immediately prior to the date of collection of the semen;] II.4.8. comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24): (1) either [II.4.8.1. they have been kept for at least 60 days prior to and during collection of the semen in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of collection of the semen and during the collection period;] (1) (10) or [II.4.8.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of collection of the semen and during the collection period;] (1) and/or [II.4.8.4. they have been kept in a vector-protected establishment for at least 60 days prior to the date of collection of the semen and during the collection period;] (1) and/or [II.4.8.5. they have been subjected to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus, with negative results, between 28 and 60 days from the date of each collection of the semen;] (1) and/or [II.4.8.6. they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on blood samples taken at the date of commencement and the date of final collection of the semen and during the collection period at intervals of at least every 7 days, in the case of the virus isolation test, or of at least every 28 days, in the case of PCR;] II.4.9. comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV): (1) either [II.4.9.1. they have been kept for at least 60 days prior to the date of collection of the semen and during the collection period in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishments for at least the preceding 2 years;] (1) (11) or [II.4.9.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of collection of the semen and during the collection period;] (1) and/or [II.4.9.3. they have been kept in a vector-protected establishment for at least 60 days prior to the date of collection of the semen and during the collection period;] (1) and/or [II.4.9.4. they were resident in the third country or territory, or zone thereof of dispatch of the semen of the consignment to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory: (1) either [II.4.9.4.1. a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, at least every 60 days throughout the collection period and between 28 and 60 days from the date of the final collection of the semen.]] (1) and/or [II.4.9.4.2. an agent identification test for EHDV, with negative results, on blood samples taken at the date of commencement and the date of the final collection of the semen and during the collection of the semen at intervals of at least every 7 days, in the case of virus isolation test, or of at least every 28 days, in the case of PCR.]] II.4.10. have been subjected to the following tests, carried out on samples taken within the last 30 days prior to the date of commencement of the quarantine referred to in point II.4.6, with negative results, except for the bovine viral diarrhoea antibody test referred to in point II.4.10.5.2, required in accordance with Part 1, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686: II.4.10.1. for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), an intradermal tuberculin test referred to in Part 2, point 1, of Annex I to Delegated Regulation (EU) 2020/688; II.4.10.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688; (1) (6) [II.4.10.3. for enzootic bovine leukosis, a serological test referred to in Part 4, point (a) of Annex I to Delegated Regulation (EU) 2020/688;] II.4.10.4. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample if the animals do not come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis; II.4.10.5. for bovine viral diarrhoea: II.4.10.5.1. a virus isolation test, a test for virus genome or a test for virus antigen, and II.4.10.5.2. a serological test to determine the presence or absence of antibodies; II.4.11. have been subjected to the following tests, carried out on samples taken at least 21 days, or 7 days in the case of the tests referred to in points II.4.11.4 and II.4.11.5, after the date of commencement of the quarantine referred to in point II.4.6, with negative results, except for the bovine viral diarrhoea antibody test referred to in point II.4.11.3.2, required in accordance with Part 1, Chapter I, point 1(c), of Annex II to Delegated Regulation (EU) 2020/686: II.4.11.1. for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688; II.4.11.2. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample; II.4.11.3. for bovine viral diarrhoea: II.4.11.3.1. a virus isolation test, a test for virus genome or a test for virus antigen, and II.4.11.3.2. a serological test to determine the presence or absence of antibodies; II.4.11.4. for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis): (1) either [II.4.11.4.1. a single test carried out on a sample of artificial vagina washings or preputial specimen, in the case of animals less than 6 months old or kept since that age in a single sex group without contact with females prior to the quarantine referred to in point II.4.6;] (1) and/or [II.4.11.4.2. tests carried out on samples of artificial vagina washings or preputial specimens taken on three occasions at intervals of at least 7 days;] II.4.11.5. for trichomonosis (Trichomonas foetus): (1) either [II.4.11.5.1. a single test carried out on a sample of preputial specimen, in the case of animals less than 6 months old or kept since that age in a single sex group without contact with females prior to the quarantine referred to in point II.4.6;] (1) and/or [II.4.11.5.2. tests carried out on preputial specimens taken on three occasions at intervals of at least 7 days;] II.4.12. have been subjected at semen collection centre, at least once a year, to the following compulsory routine tests, required in accordance with Part 1, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686: II.4.12.1. for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), an intradermal tuberculin test referred to in Part 2, point 1, of Annex I to Delegated Regulation (EU) 2020/688; II.4.12.2. for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688; II.4.12.3. for enzootic bovine leukosis, a serological test referred to in Part 4, point (a), of Annex I to Delegated Regulation (EU) 2020/688; II.4.12.4. for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample; (1) (7) [II.4.12.5. for bovine viral diarrhoea, a serological test for detection of an antibody;] (1) (8) [II.4.12.6. for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis), a test on a sample of preputial specimen;] (1) (8) [II.4.12.7. for trichomonosis (Trichomonas foetus), a test on a sample of preputial specimen;] II.5. The semen of the consignment described in Part I: II.5.1. has been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686; II.5.2. is placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.5.3. is transported in a container which: II.5.3.1. was sealed and numbered prior to the date of dispatch to the Union from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; (1) (4) [II.5.3.3. has been filled in with a cryogenic agent which has not been previously used for other products.] (1) [II.6. Where an antibiotic or a mixture of antibiotics was added to the semen: II.6.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: … (9); II.6.2. Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 5 °C, or under a time-temperature regime with a documented equivalent bactericidal activity.] Notes This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Indicate semen. “Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate “point II.4.8.5” or “point II.4.8.6”, or both, and for EHD-test, indicate “point II.4.9.4.1” or “point II.4.9.4.2”, or both, if relevant. Part II: (1) Delete if not applicable. (2) Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (3) Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. (4) Applicable to frozen semen. (5) Applicable to fresh and chilled semen. (6) Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and which are less than 2 years of age as referred to in Article 20(2), point (a), of Delegated Regulation (EU) 2020/686. (7) Applicable only to seronegative animals. (8) Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls returning to collection after a lay-off period of more than 6 months shall be tested during the last 30 days prior to resuming production. (9) Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotics. (10) Applicable only for the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (11) Applicable only for the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 40
MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 88/407/EEC AS AMENDED BY COUNCIL DIRECTIVE 2003/43/EC, AFTER 31 DECEMBER 2004 AND BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-B-ENTRY”)
Part I: Description of consignment
| COUNTRY | Animal health certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| --- | --- |
| I.18 | Transport conditions |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| --- | --- |
| I.21 | ☐ For transit |
| Third country | |
| --- | --- |
| I.24 | Total number of packages |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
| Type | |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model BOV-SEM-B-ENTRY | Certificate model BOV-SEM-B-ENTRY | Certificate model BOV-SEM-B-ENTRY | Certificate model BOV-SEM-B-ENTRY |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| I, the undersigned official veterinarian, hereby certify that: II.1. … (name of exporting country or part thereof) (1) was free from rinderpest and foot-and-mouth disease during the 12 month period immediately prior to collection of the semen for export and until its date of dispatch to the Union and no vaccination against these diseases has taken place during the same period. II.2. The centre (2) described in box I.11. at which the semen to be exported was collected: II.2.1. met the conditions laid down in Chapter I(1) of Annex A to Directive 88/407/EEC; II.2.2. was operated and supervised in accordance with the conditions laid down in Chapter II(1) of Annex A to Directive 88/407/EEC. II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, brucellosis, anthrax and contagious bovine pleuropneumonia during 30 days prior to the date of collection of the semen to be exported and the 30 days after collection (in the case of fresh semen until the day of dispatch to the Union). II.4. The bovine animals standing at the semen collection centre: (3) II.4.1. come from herds which satisfy the conditions of paragraph 1(b) of Chapter I of Annex B to Directive 88/407/EEC; II.4.2. come from herds or were born to dams which comply with the conditions of paragraph 1(c) of Chapter I of Annex B to Directive 88/407/EEC, or were tested at the age of at least 24 months in accordance with paragraph 1(c) of Chapter II of Annex B to that Directive; II.4.3. underwent the tests required in accordance with paragraph 1(d) of Chapter I of Annex B to Directive 88/407/EEC in the 28 days preceding the quarantine isolation period; II.4.4. have satisfied the quarantine isolation period and testing requirements laid down in paragraph 1(e) of Chapter I of Annex B to Directive 88/407/EEC; II.4.5. have undergone, at least once a year, the routine tests referred to in Chapter II of Annex B to Directive 88/407/EEC. II.5. The semen to be exported was obtained from donor bulls which: II.5.1. satisfy the conditions laid down in Annex C to Directive 88/407/EEC; (4) either [II.5.2. have remained in the exporting country for at least 6 months prior to collection of the semen to be exported; (4) or [II.5.2. have remained in the exporting country for at least 30 days prior to the collection of the semen since entry and they were imported from … (1)during the period of less than 6 months prior to the collection of the semen and satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union;] II.5.3. comply with at least one of the following conditions as regards bluetongue, as detailed in the table in box I.27: (4) either [II.5.3.1. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;] (4) and/or [II.5.3.2. were kept during a bluetongue virus seasonally-free period in a seasonally-free zone for at least 60 days prior to, and during, collection of the semen;] (4) and/or [II.5.3.3. were kept in a vector-protected establishment for at least 60 days prior to, and during, collection of the semen;] (4) and/or [II.5.3.4. were subjected to a serological test for the detection of antibody to the bluetongue virus serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;] (4) and/or [II.5.3.5. were subjected to an agent identification test for bluetongue virus, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, on blood samples taken at commencement and final collection for this consignment of semen and at least every 7 days (virus isolation test) or at least every 28 days, if carried out as polymerase chain reaction (PCR), during collection for this consignment of semen;] II.5.4. comply with at least one of the following conditions as regards epizootic haemorrhagic disease (EHD), as detailed in the table in box I.27: (4) either [II.5.4.1. were resident in the exporting country which according to official findings is free from epizootic haemorrhagic disease (EHD);] (4) (5) and/or [II.5.4.2. were resident in the exporting country in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were subjected with negative results in each case to the following tests carried out in an approved laboratory: (4) either [II.5.4.2.1. a serological test (6) for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken on 2 occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of semen;]] (4) and/or [II.5.4.2.2. a serological test (6) for the detection of antibody to the EHD virus serogroup, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]] (4) and/or [II.5.4.2.3. an agent identification test (6) carried out on blood samples collected at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days, if carried out as PCR, during collection for this consignment of semen.]] II.6. The semen to be exported was collected after the date on which the centre was approved by the competent national authorities of the exporting country. II.7. The semen to be exported was processed, stored and transported under conditions which satisfy the terms of Directive 88/407/EEC. Notes This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centre listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws of semen collected on a particular date from an identified donor bull complying with particular conditions for bluetongue and EHD. Part II: (1) Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for semen of bovine animals. (2) Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. (3) For New Zealand, appearing with an entry “XII” in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p.1), officially tuberculosis-free bovine herds shall be considered equivalent to officially tuberculosis-free bovine herds in the Member States recognised based on the conditions laid down in paragraphs 1 and 2 of Annex A.I to Council Directive 64/432/EEC. (4) Delete if not applicable. (5) Compulsory for Australia, Canada and the United States. (6) The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 41
MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 88/407/EEC AS AMENDED BY COUNCIL DIRECTIVE 93/60/EEC, BEFORE 1 JANUARY 2005, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-C-ENTRY”)
Part I: Description of consignment
| COUNTRY | Animal health certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| --- | --- |
| I.18 | Transport conditions |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| --- | --- |
| I.21 | ☐ For transit |
| Third country | |
| --- | --- |
| I.24 | Total number of packages |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
| Type | |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model BOV-SEM-C-ENTRY | Certificate model BOV-SEM-C-ENTRY | Certificate model BOV-SEM-C-ENTRY | Certificate model BOV-SEM-C-ENTRY |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| I, the undersigned official veterinarian, hereby certify that: II.1. … (name of exporting country) (1) has been free from rinderpest and foot-and-mouth disease during the 12-month period immediately prior to collection of the semen for export and until its date of dispatch and no vaccination against these diseases has taken place during the same period. II.2. The semen described above was collected before 31 December 2004 at the semen collection centre (2) which: II.2.1. met the conditions laid down in Chapter I of Annex A to Directive 88/407/EEC; II.2.2. was operated and supervised in accordance with the conditions laid down in Chapter II of Annex A to Directive 88/407/EEC. II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, brucellosis, anthrax and contagious bovine pleuropneumonia during the period commencing 30 days prior to the date of collection of the semen to be exported and the 30 days after collection. II.4. At the time semen described above was collected, all bovine animals standing at the semen collection centre: II.4.1. came from herds and/or were born to dams which satisfy the conditions of paragraph 1(b) and (c) of Chapter I of Annex B to Directive 88/407/EEC; II.4.2. had tested negative, within the 30 days preceding the quarantine isolation period, to: — the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to Directive 88/407/EEC, and — a serum neutralization test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis, and — a virus isolation test (fluorescent antibody test or immunoperoxidase test) for bovine viral diarrhoea, deferred until the animal reached the age of 6 months in the case of younger animals; II.4.3. had undergone the 30-day quarantine isolation period and had tested negative to the following health tests: — a serological test for brucellosis carried out in accordance with the procedure described in Annex C to Directive 64/432/EEC; — either an immunofluorescent antibody test or a culture test for Campylobacter fetus infection on a sample of preputial material or artificial vagina washings, or, in the case of a female animal, a vaginal mucus agglutination test; — a microscopic examination and culture test for Trichomonas foetus on a sample of preputial material or artificial vagina washings, or in the case of a female animal a vaginal mucus agglutination test; II.4.4. had tested negative, at least once a year, to the routine tests referred to in points 1(a), (b) and (c) of Chapter II of Annex B to Directive 88/407/EEC. II.5. At the time the semen described in Part I was collected, II.5.1. all female bovine animals in the centre had tested negative at least once a year to a vaginal mucus agglutination test for Campylobacter fetus infection, and II.5.2. all bulls used for semen production had tested negative either to an immunofluorescent antibody test or to a culture test for Campylobacter fetus infection on a sample of preputial material or artificial vagina washings carried out in 12 months prior to collection. II.6. The semen to be exported was obtained from donor bulls which: II.6.1. satisfy the conditions laid down in Annex C to Directive 88/407/EEC; (3) either [II.6.2. were resident in the exporting country during the 6 months immediately prior to collection of the semen for export;] (3) or [II.6.2. were imported from … (1) after spending less than 6 months in the exporting country and at the time of import satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union;] II.6.3. stand in a semen collection centre at which: (3) either [all bovine animals were not vaccinated against infectious bovine rhinotracheitis and tested negative at least once a year to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis;] (3) or [bovine animals not vaccinated against infectious bovine rhinotracheitis tested negative, at least once a year, to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis, at which testing for infectious bovine rhinotracheitis was not carried out on bulls which had received their first vaccination against infectious bovine rhinotracheitis at the insemination centre after they had tested negative to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis and which had been regularly re-vaccinated at intervals of not more than 6 months since the first vaccination;] (3) either [II.6.4. have not been vaccinated against infectious bovine rhinotracheitis,] (3) or [II.6.4. have been vaccinated against infectious bovine rhinotracheitis in accordance with point II.6.3,] II.6.5. fulfil the import conditions for bovine semen laid down in the Bluetongue Chapter of the Terrestrial Animal Health Code of the OIE, depending on the status of the country or zone of residence; II.6.6. were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and tested negative on two occasions not more than 12 months apart to an agar-gel immuno-diffusion test (4) and to a virus neutralization test for all above-listed serotypes of EHD, carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen; II.6.7. were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and tested negative, prior to entry and at 6-monthly intervals, to an agar-gel immuno-diffusion test(4) and a virus neutralization test for all above-listed serotypes of EHD, carried out in approved laboratory; II.6.8. tested negative on two occasions not more than 12 months apart to a serum neutralization test for Akabane virus carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen. II.7. The semen to be exported was collected after the date on which the centre was approved by the competent national authorities of the exporting country. II.8. The semen to be exported was processed, stored and transported under conditions which satisfy the terms of Directive 88/407/EEC prior to its amendment by Directive 2003/43/EC. Notes This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centre listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” shall be prior to 31 December 2004 and indicated in the following format: dd/mm/yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws of semen collected on a particular date from an identified donor bull complying with particular conditions for bluetongue and EHD. Part II:** (1) Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for semen of bovine animals. (2) Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm. (3) Delete if not applicable. (4) The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. To be used only by Australia, Canada and the United States. *** To be used only by Australia and the United States. ** To be used only by Canada. * To be used only by Australia. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 42
MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF BOVINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “BOV-OOCYTES-EMB-A-ENTRY”)
Part I: Description of consignment
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.
This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence.
EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.